PLPL Financials Tuesday, July 15, 2014 06:14:55 AM
Plandai Biotechnology, Inc.
Period Ending Jun 30, 2013 Jun 30, 2012 Jun 30, 2011 Mar 31, 2011
Total Revenue 359 74 - 7,163
Cost of Revenue 963 - 113 5,273
Gross Profit (604) 74 (113) 1,890
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 1,919 3,884 23 2,352
Non-Recurring Items - - - -
Other 135 - - 23
Operating Income (2,658) (3,810) (136) (485)
Income From Continuing Operations
Add'l Income/Expense Items (45) - 53 22
Earnings Before Interest and Tax (2,703) (3,810) (83) (463)
Interest Expense 265 29 2 85
Earnings Before Tax (2,968) (3,838) (85) (548)
Income Tax - - - -
Minority Interest (780) (61) (15) -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (2,188) (3,777) (70) (548)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (2,188) (3,777) (70) (548)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (2,188) (3,777) (70) (548)